DiaMedica Therapeutics (DMAC) Operating Leases (2019 - 2026)
DiaMedica Therapeutics' (DMAC) quarterly Operating Leases came in at $96000.0 in Q1 2026, down 52.24% year-on-year from $201000.0 in Q1 2025, and down 22.58% quarter-over-quarter from $124000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Operating Leases (2019 - 2026) Analysis & Trends
DiaMedica Therapeutics' Operating Leases history runs 8 years deep, the most recent figure standing at $96000.0 for Q1 2026.
- On a quarterly basis, Operating Leases fell 52.24% year-over-year to $96000.0 in Q1 2026; TTM through Mar 2026 was $96000.0, a 52.24% decrease from a year earlier, with the FY2025 full-year figure at $124000.0, down 44.89% from the prior year.
- Operating Leases slipped to $96000.0 in Q1 2026 per DMAC's latest filing, from $124000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $459000.0 in Q3 2022 and bottomed at $4000.0 in Q2 2023.
- The 5-year median for Operating Leases is $316000.0 (2023), against an average of $273705.9.
- Across the five-year window, Operating Leases jumped 13100.0% in 2022 and tumbled 99.1% in 2023, its largest moves.
- Year by year, Operating Leases stood at $396000.0 in 2022, then retreated by 20.2% to $316000.0 in 2023, then retreated by 28.8% to $225000.0 in 2024, then plunged by 44.89% to $124000.0 in 2025, then decreased by 22.58% to $96000.0 in 2026.
- Per Business Quant, the three latest DMAC Operating Leases figures stand at $96000.0 (Q1 2026), $124000.0 (Q4 2025), and $150000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | DiaMedica Therapeutics | 366.87 Mn | 366.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 96,000.00 |
| Dec 31, 2025 | 124,000.00 |
| Sep 30, 2025 | 150,000.00 |
| Jun 30, 2025 | 272,000.00 |
| Mar 31, 2025 | 201,000.00 |
| Dec 31, 2024 | 225,000.00 |
| Sep 30, 2024 | 337,000.00 |
| Jun 30, 2024 | 357,000.00 |
| Mar 31, 2024 | 377,000.00 |
| Dec 31, 2023 | 316,000.00 |
| Sep 30, 2023 | 415,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 450,000.00 |
| Dec 31, 2022 | 396,000.00 |
| Sep 30, 2022 | 459,000.00 |
| Jun 30, 2022 | 446,000.00 |
| Mar 31, 2022 | 28,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 60,000.00 |
| Jun 30, 2021 | 75,000.00 |